Facilitating Implicit Learning to Improve Neurorehabilitation in Stroke
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02017574 |
|
Recruitment Status :
Completed
First Posted : December 20, 2013
Results First Posted : February 10, 2017
Last Update Posted : March 28, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Cerebral Stroke | Behavioral: Reaching Task | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 24 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Basic Science |
| Official Title: | Facilitating Implicit Learning to Improve Neurorehabilitation in Stroke |
| Study Start Date : | October 2013 |
| Actual Primary Completion Date : | September 2015 |
| Actual Study Completion Date : | September 2016 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Implicit Group
Receives little feedback about task performance during learning
|
Behavioral: Reaching Task
Learn a reaching task that requires coordination of the arm segments |
|
Active Comparator: Control
Receives detailed feedback about task performance during learning
|
Behavioral: Reaching Task
Learn a reaching task that requires coordination of the arm segments |
- Quality of Motor Performance [ Time Frame: 2 Years ]Quality of motor behavior was indexed by the percentage of samples in which the participants were within the trained (i.e. optimal) trajectory. The trained trajectory was a 2cm wide channel in the shape of a half circle between two targets which were 25cm apart from each other. Therefore, the scale measure is a percentage which can range between 0 and 100%.
- EEG Derived High Alpha Power [ Time Frame: 2 Years ]Brain electrophysiology measure of attentional processes as indexed by high alpha power (10-13 Hz). The unit of measurement is a percentage as the amount of power (microvolts squared) in the high alpha band was divided by the total power in the spectrum (i.e. 1-50 Hz). This method is commonly employed to normalize the power of a particular frequency if the statistical design includes a between subjects factor.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 45 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Ischemic stroke greater than 3 months prior.
- Between 45 and 80 years of age.
- Residual hemiparetic upper extremity deficits.
- Adequate language and neurocognitive function to participate in training (MMSE, CESD, aphasia screening).
- Right hand dominant.
- Upper Extremity Fugl-Meyer score of 25 or greater.
Exclusion Criteria:
- History of cortical stroke.
- No mobility of less affected arm.
- Failure to meet the RRDC assessment clinic criteria for medical eligibility.
- MMSE score less than 27.
- CES-D score greater than 16.
- Unable to pass a hearing test (i.e. must be able to hear sounds of 45 dB or less).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02017574
| United States, Maryland | |
| Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD | |
| Baltimore, Maryland, United States, 21201 | |
| Principal Investigator: | Jeremy C Rietschel, PhD MA BA | Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD |
| Responsible Party: | VA Office of Research and Development |
| ClinicalTrials.gov Identifier: | NCT02017574 |
| Other Study ID Numbers: |
N0970-M |
| First Posted: | December 20, 2013 Key Record Dates |
| Results First Posted: | February 10, 2017 |
| Last Update Posted: | March 28, 2017 |
| Last Verified: | February 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Stroke Cerebral Infarction |
|
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |

